FRIDAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Synergy Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
April 11, 2019 17:23 ET
|
Schall Law
LOS ANGELES, April 11, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Synergy Pharmaceuticals...
Hagens Berman Reminds Synergy Pharmaceuticals Investors of the April 10, 2018 Lead Plaintiff Deadline and Alerts them to the Expanded Class Period
March 07, 2018 16:00 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, March 07, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) investors to the expanded class period and the April 10, 2018...
Hagens Berman Reminds Synergy Pharmaceuticals Investors of the April 10, 2018 Lead Plaintiff Deadline in the Securities Class Action Linked to Loan Disclosures
February 28, 2018 09:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) of the April 10, 2018 Lead Plaintiff deadline in the...
Hagens Berman Alerts Synergy Pharmaceuticals Investors to the Securities Class Action Concerning Loan Disclosures and to the April 10, 2018 Lead Plaintiff Deadline
February 14, 2018 16:16 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Feb. 14, 2018 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) to the securities class action pending in the United...